Technology Licensing
Our predictive analytics technology is available for licensing in the field of healthcare to improve your competitive advantage. Though VGbio is a young company, our intellectual property portfolio includes not only our own pending patent assets, but also exclusive rights in the medical and biological arts to patent assets from Argonne National Laboratory, the University of Chicago, and SmartSignal Corporation. These patent assets include more than 40 US patents, with foreign counterparts in much of the industrial world, and represent more than 20 years of research and development in empirical modeling science for sensitive monitoring of complex systems.
Our SBM technology has been commercially proven in predictive analytics for nuclear power plants, aircraft engines, refineries, vehicles and even for large computer systems. SBM can differentiate your medical human health monitoring or diagnostic product and push it past the competition. Please contact us for information about demonstrating and licensing our technology.
Some example patents in our portfolio:
- US Patent No. 6,839,655 - System for monitoring non-coincident, nonstationary process signals
- US Patent No. 6,181,975 - Industrial process surveillance system
- US Patent No. 6,952,662 - Signal differentiation system using improved non-linear operator
- US Patent No. 6,957,172 - Complex signal decomposition and modeling
- US Patent No. 6,859,739 - Global state change indicator for empirical modeling in condition based monitoring